Publications and Posters
Search our publications, posters, and presentations by title, author, journal, year, or keywords.
"Ask early about how you will evaluate the success of your efforts."Hayes-Roth et al., 1983
Good Reads
- Prediction of Efficacy for Conversion From Adjunctive Therapy to Monotherapy With Eslicarbazepine Acetate 800 mg Once Daily for Partial-onset Epilepsy
- Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites
- Interactive Code for Guiding Dose Selection
- In Silico Prediction of Oral Bioavailability
- Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
- Toward Progressive Reporting of Modeling and Simulation Results - Part 1: Analysis of KIWI Metadata
- Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function
- Population Pharmacokinetic Evaluation of Eslicarbazepine Acetate for Adjunctive Therapy in…
- Impact of Delayed-Dose Administration of USL255, Qudexy™ XR (Topiramate) Extended-Release Capsules
- Tedizolid population pharmacokinetics, exposure-response, and target attainment
- Exposure-response analysis of eslicarbazepine acetate as adjunctive treatment of patients with partial-onset seizures
- The development of a population pharmacokinetic (PK) model for linezolid
- Engineering the Pharmacometrics Enterprise
- Exposure-response analyses of tigecycline tolerability in healthy subjects
- Improving the efficiency and ensuring the quality of data assembly for pharmacometric analysis
- Pharmacometrics and the transition to model-based development
- Informatics: the fuel for pharmacometric analysis
- A new paradigm of real-time data assembly to support knowledge-based decision making: a case study
- Integrating real-time data assembly (RTDA) and population pharmacokinetics as tactical components of cognitive engineering
